HUTCHISON CHINA MEDITECH LTD's ticker is HCM and the CUSIP is 44842L103. A total of 129 filers reported holding HUTCHISON CHINA MEDITECH LTD in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $3,777,162 | +61.3% | 255,559 | -3.3% | 0.01% | +66.7% |
Q3 2022 | $2,341,000 | +21.8% | 264,220 | +73.7% | 0.01% | +20.0% |
Q2 2022 | $1,922,000 | -68.9% | 152,103 | -53.5% | 0.01% | -28.6% |
Q1 2022 | $6,190,000 | +64.5% | 327,196 | +205.0% | 0.01% | -12.5% |
Q4 2021 | $3,763,000 | -19.7% | 107,290 | -16.2% | 0.01% | -33.3% |
Q3 2021 | $4,686,000 | -15.1% | 128,011 | -8.9% | 0.01% | -20.0% |
Q2 2021 | $5,518,000 | +37.4% | 140,514 | -1.2% | 0.02% | +7.1% |
Q1 2021 | $4,017,000 | +2.0% | 142,173 | +15.6% | 0.01% | -6.7% |
Q4 2020 | $3,940,000 | +4.3% | 123,035 | +5.2% | 0.02% | -21.1% |
Q3 2020 | $3,779,000 | -19.1% | 116,990 | -30.9% | 0.02% | -32.1% |
Q2 2020 | $4,671,000 | +55.1% | 169,331 | +0.4% | 0.03% | +16.7% |
Q1 2020 | $3,012,000 | -35.7% | 168,720 | -9.6% | 0.02% | -17.2% |
Q4 2019 | $4,682,000 | +36.5% | 186,738 | -2.9% | 0.03% | +20.8% |
Q3 2019 | $3,431,000 | +1152.2% | 192,298 | +2049.1% | 0.02% | +1100.0% |
Q1 2019 | $274,000 | – | 8,948 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Zeal Asset Management Ltd | 421,140 | $5,075,000 | 10.46% |
Capital International, Inc./CA/ | 4,151,900 | $52,480,000 | 0.73% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 859 | $68,000,000 | 0.71% |
GENERAL ATLANTIC, L.P. | 4,000,000 | $50,560,000 | 0.66% |
Capital International Sarl | 544,653 | $6,884,000 | 0.55% |
M&G INVESTMENT MANAGEMENT LTD | 6,977,228 | $90,704,000 | 0.54% |
E Fund Management (Hong Kong) Co., Ltd. | 58,861 | $744,000 | 0.51% |
Bellevue Group AG | 1,756,307 | $21,359,000 | 0.30% |
AIA Group Ltd | 356,640 | $4,508,000 | 0.24% |
PLATINUM INVESTMENT MANAGEMENT LTD | 224,634 | $2,839,000 | 0.11% |